data_1qg9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qg9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.441 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.3 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.441 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 16' ' ' ILE . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' N ' HD21 ' A' ' 15' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' CD2' HD11 ' A' ' 16' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.308 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.3 t80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.466 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.464 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 4.1 t80 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.464 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.478 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 12' ' ' PHE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.474 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 18' ' ' ILE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.17 0.51 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.439 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.423 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.4 t80 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.27 0.557 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 15' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.414 ' CD2' HD21 ' A' ' 15' ' ' LEU . 1.3 pp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.0 t80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.416 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 19' ' ' LEU . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.422 ' CD2' HD22 ' A' ' 15' ' ' LEU . 3.3 pp . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 1.1 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.491 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 15' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CE2' ' OH ' ' A' ' 10' ' ' TYR . 2.7 t80 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.335 0.588 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.399 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.476 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 3.9 t80 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 1.4 pp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.42 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 2.5 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 19' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD22 ' A' ' 15' ' ' LEU . 1.8 pp . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.2 t80 . . . . . 0 C--O 1.237 0.416 0 CA-C-O 121.347 0.594 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 19' ' ' LEU . 1.2 mt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.494 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.465 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.216 0.532 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.465 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.46 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 2.1 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 15' ' ' LEU . 6.9 mp . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.1 t -100.6 -70.24 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -114.73 -49.79 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -73.46 98.04 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 p -90.14 -81.91 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.441 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.3 t80 -49.11 -66.95 0.31 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD21 ' N ' ' A' ' 16' ' ' ILE . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' N ' HD21 ' A' ' 15' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -67.06 -18.31 65.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.54 70.44 1.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.753 0.311 . . . . 0.0 111.212 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.82 -34.77 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.18 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -148.6 -52.78 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.745 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.55 121.01 22.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.337 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -82.82 -50.64 8.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.788 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -46.38 -67.34 0.29 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.69 -46.42 88.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.69 70.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.84 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 t -72.87 -24.35 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -108.1 105.85 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -151.34 -59.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -81.18 -33.64 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -44.97 -68.65 0.18 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' CD2' HD11 ' A' ' 16' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.42 HD11 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.78 -20.08 65.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.11 60.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.842 0.353 . . . . 0.0 111.449 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.82 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.37 -36.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.77 -160.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -52.27 128.09 24.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -97.68 -39.55 9.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.515 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.52 -70.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.39 -21.79 66.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.59 -35.39 77.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.734 0.302 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.878 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.46 -50.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.222 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.73 74.98 1.41 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.022 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -99.96 -29.12 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.3 p -90.08 -38.95 13.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.05 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.3 t80 -49.69 -59.82 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.466 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.73 -22.98 65.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -43.81 59.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.884 0.373 . . . . 0.0 111.201 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.928 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.842 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t -112.76 8.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.39 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.3 -35.25 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.293 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.88 -32.44 8.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 111.03 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -56.75 -64.29 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 -45.36 89.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.17 48.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.264 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.017 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.785 0.326 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.32 -25.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -77.11 166.04 23.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.33 153.73 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -52.46 63.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -65.54 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.266 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pp -71.86 -25.49 61.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.97 79.73 1.83 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.8 m120 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.52 -41.14 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -179.84 48.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.64 -63.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.41 -33.52 59.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.088 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.464 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 4.1 t80 -48.61 -66.21 0.44 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.464 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.478 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 HD12 ' CE1' ' A' ' 12' ' ' PHE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 pp -65.52 -20.65 66.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.61 -51.79 14.99 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.9 0.381 . . . . 0.0 111.656 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.948 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.789 0.328 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.95 -49.13 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.152 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.61 117.96 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -99.28 175.53 5.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.278 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -59.35 -56.34 23.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -47.7 -59.49 3.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.474 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 18' ' ' ILE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.87 -18.34 62.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.17 25.51 2.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.583 0.23 . . . . 0.0 111.553 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.82 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.92 0.39 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.37 -41.22 80.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.236 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.19 118.22 33.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.941 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -70.12 162.32 28.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.0 t -115.44 -50.0 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.1 0.476 . . . . 0.0 111.132 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.433 ' N ' ' CG2' ' A' ' 5' ' ' THR . 1.4 t80 -48.33 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.439 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp -65.48 -24.9 67.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.52 53.88 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.4 -59.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -147.26 95.54 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -110.61 155.31 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.221 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -69.37 -47.24 64.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -68.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.35 -14.42 59.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.38 64.86 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.77 0.319 . . . . 0.0 111.347 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.986 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.789 0.328 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.11 -45.49 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.59 2.27 17.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.966 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -119.27 167.27 12.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.997 0.427 . . . . 0.0 111.094 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 5.9 t -160.68 -47.95 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.334 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' N ' ' CG2' ' A' ' 5' ' ' THR . 1.4 t80 -48.46 -60.59 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.055 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.437 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HD11 ' CD2' ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.06 -22.24 60.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.44 -58.77 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.058 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.84 0.352 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.12 -26.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.31 66.03 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -179.31 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.097 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -65.13 -49.68 68.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.104 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.77 -66.75 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -69.99 -11.11 60.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.97 64.09 1.57 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.959 179.941 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -121.09 -51.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.066 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -113.03 145.62 40.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -101.51 159.23 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.175 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.428 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.9 t -53.05 -49.21 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.208 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' N ' ' CG2' ' A' ' 5' ' ' THR . 1.7 t80 -46.72 -69.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.462 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 HD12 ' CD2' ' A' ' 15' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' CD2' HD21 ' A' ' 15' ' ' LEU . 1.3 pp -67.23 -22.59 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.06 74.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.781 0.324 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.814 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.69 -67.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -106.33 35.16 3.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -100.34 97.69 8.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -93.77 -77.78 0.45 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -49.89 -69.4 0.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.22 -11.5 57.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 36.62 1.05 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 111.3 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.066 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 4' ' ' TYR . 19.9 t -77.84 -23.95 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 74.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -144.78 154.48 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.757 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -89.33 -51.46 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.416 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -51.37 -69.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.913 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.416 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 19' ' ' LEU . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.409 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.422 ' CD2' HD22 ' A' ' 15' ' ' LEU . 3.3 pp -84.03 5.77 24.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.32 35.29 4.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.891 0.377 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 t -115.53 -21.79 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.596 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -146.94 84.11 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -179.39 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.849 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 3.3 p -81.83 -37.39 27.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.948 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 1.1 t80 -49.12 -70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.196 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 5' ' ' THR . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 ' N ' HD22 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD13 ' N ' ' A' ' 20' ' ' ALA . 4.6 pp -66.5 -21.62 66.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -61.58 -37.4 83.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.742 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.853 0.359 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.75 -67.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -74.91 115.17 14.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -176.14 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -62.54 -39.6 94.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -68.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.491 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -66.47 -21.58 66.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.53 -44.96 46.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 111.268 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.932 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.0 -13.88 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 67.73 119.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.37 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -174.38 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -44.13 86.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -54.68 -63.55 1.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' N ' HD21 ' A' ' 15' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pp -72.22 -25.4 61.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -54.93 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.203 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.753 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 2' ' ' VAL . 24.8 t 51.9 24.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.496 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.09 -28.96 60.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.47 168.3 9.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.4 t -92.59 -49.85 5.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.268 0.556 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' CE2' ' OH ' ' A' ' 10' ' ' TYR . 2.7 t80 -49.27 -64.63 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.71 -43.31 69.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.87 44.32 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.032 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.931 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 m120 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.812 0.339 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 t -104.17 -40.26 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.159 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -129.8 72.46 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -50.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.65 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.424 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 6.1 t -51.52 -47.91 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 110.526 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.476 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -46.63 -65.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.399 179.802 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.476 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.36 10.54 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.1 -59.48 2.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.137 -179.837 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.842 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.26 -41.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -98.62 129.66 45.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -73.94 93.36 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.466 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.63 -36.84 69.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -46.95 -69.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -85.11 12.45 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.22 46.32 1.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 111.185 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.991 179.899 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.411 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 13.2 t-20 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 1' ' ' ASN . 56.1 t -157.61 -44.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.51 111.35 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.49 143.05 50.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 p -73.54 -63.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.436 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 3.9 t80 -44.81 -68.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.404 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 16' ' ' ILE . 1.4 pp -68.69 -13.3 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.02 -24.04 22.58 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.084 -179.766 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 t -72.24 -28.8 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -65.54 81.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -79.86 99.48 7.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.911 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -82.47 -43.74 16.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.42 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 2.5 t80 -48.65 -57.32 6.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.56 11.95 9.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.07 25.14 9.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 111.084 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.896 -179.952 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.865 0.365 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t -105.22 -49.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.286 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.29 22.02 5.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.283 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.94 -72.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.749 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 5.4 t -56.18 -48.38 76.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.423 ' N ' ' CG2' ' A' ' 5' ' ' THR . 1.1 t80 -42.49 -68.44 0.19 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.863 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 19' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' CD2' HD22 ' A' ' 15' ' ' LEU . 1.8 pp -73.88 -11.29 60.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.78 -32.25 5.77 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.739 0.304 . . . . 0.0 111.581 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.983 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.41 -42.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.912 179.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -115.64 102.18 9.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 179.564 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -81.67 -17.6 47.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.887 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -32.75 20.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.082 0.468 . . . . 0.0 110.751 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 1.2 t80 -51.09 -64.07 0.93 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.696 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 19' ' ' LEU . 1.2 mt -71.31 -38.31 71.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.06 79.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.927 -179.955 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.75 0.309 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.82 -41.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.907 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.74 97.78 5.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.61 143.04 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -67.52 -49.28 64.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.9 0.381 . . . . 0.0 111.152 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -47.38 -68.69 0.17 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.494 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.494 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pp -83.43 -20.15 34.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.67 64.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.702 0.287 . . . . 0.0 111.505 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.33 -56.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.92 44.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.593 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.11 159.83 42.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.179 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.426 HG21 ' N ' ' A' ' 6' ' ' PHE . 3.0 t -94.74 -47.17 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.417 0.627 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.465 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -45.68 -56.5 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.405 179.941 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.84 -24.54 65.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.37 -37.66 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.368 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.894 -179.892 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.59 -47.51 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.337 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -135.68 151.89 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -86.82 85.42 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -75.23 -48.32 23.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.46 ' CZ ' ' OH ' ' A' ' 10' ' ' TYR . 2.1 t80 -49.07 -69.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.21 -18.27 64.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.76 34.26 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.894 0.378 . . . . 0.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.835 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.66 -51.41 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.252 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.71 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 p -79.21 -35.46 41.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -49.29 -60.29 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CZ ' HD23 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' CZ ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 15' ' ' LEU . 6.9 mp -56.11 -47.19 78.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.84 53.86 2.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.247 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.154 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.561 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 15' ' ' LEU . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 19' ' ' LEU . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.614 ' HA ' HD21 ' A' ' 19' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' PHE . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 12' ' ' PHE . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.3 t80 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 6' ' ' PHE . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.731 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.9 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.308 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 6' ' ' PHE . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 12' ' ' PHE . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 6' ' ' PHE . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' ILE . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 15' ' ' LEU . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.2 pp . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.6 t80 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 6' ' ' PHE . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 6' ' ' PHE . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.632 ' N ' HD23 ' A' ' 15' ' ' LEU . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 4.1 t80 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 15' ' ' LEU . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 15' ' ' LEU . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.7 pp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 12' ' ' PHE . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.803 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.17 0.51 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' THR . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' LEU . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 6' ' ' PHE . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' PHE . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.488 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.27 0.557 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 11' ' ' THR . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.79 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.544 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 19' ' ' LEU . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 12' ' ' PHE . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 15' ' ' LEU . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.7 t80 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 6' ' ' PHE . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' HD13 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 19' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 16' ' ' ILE . 1.3 pp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.761 ' HA ' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 6' ' ' PHE . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' PHE . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 16' ' ' ILE . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.3 pp . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.1 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 6' ' ' PHE . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.706 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.6 pp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 16' ' ' ILE . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 12' ' ' PHE . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 18' ' ' ILE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.523 ' HA ' HD21 ' A' ' 19' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 15' ' ' LEU . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.0 pp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.7 t80 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.335 0.588 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.48 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.399 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 6' ' ' PHE . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 19' ' ' LEU . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' CD2' HD23 ' A' ' 15' ' ' LEU . 1.7 pp . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.69 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.9 t80 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD13 HD21 ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 HD13 ' A' ' 16' ' ' ILE . 1.4 pp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.5 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 6' ' ' PHE . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 15' ' ' LEU . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.2 t80 . . . . . 0 C--O 1.237 0.416 0 CA-C-O 121.347 0.594 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 16' ' ' ILE . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 12' ' ' PHE . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.2 mt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.541 HD11 ' HE1' ' A' ' 12' ' ' PHE . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.4 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.216 0.532 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 16' ' ' ILE . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.62 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' THR . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 6' ' ' PHE . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 12' ' ' PHE . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 15' ' ' LEU . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.4 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 6' ' ' PHE . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 12' ' ' PHE . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' CD1' HD12 ' A' ' 15' ' ' LEU . 6.9 mp . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.436 HG12 ' HG3' ' A' ' 3' ' ' GLU . 53.1 t -100.6 -70.24 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HG3' HG12 ' A' ' 2' ' ' VAL . 31.4 mt-10 -114.73 -49.79 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -73.46 98.04 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 p -90.14 -81.91 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 -49.11 -66.95 0.31 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 15' ' ' LEU . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 19' ' ' LEU . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.614 ' HA ' HD21 ' A' ' 19' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -67.06 -18.31 65.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.54 70.44 1.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.753 0.311 . . . . 0.0 111.212 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.82 -34.77 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.18 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -148.6 -52.78 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.745 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.408 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -76.55 121.01 22.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.337 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -82.82 -50.64 8.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.788 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -46.38 -67.34 0.29 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 4' ' ' TYR . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' PHE . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 12' ' ' PHE . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.69 -46.42 88.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.69 70.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.84 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 t -72.87 -24.35 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -108.1 105.85 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -151.34 -59.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -81.18 -33.64 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.3 t80 -44.97 -68.65 0.18 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 6' ' ' PHE . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.731 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.9 pp -66.78 -20.08 65.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.11 60.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.842 0.353 . . . . 0.0 111.449 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.82 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.37 -36.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.77 -160.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -52.27 128.09 24.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -97.68 -39.55 9.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.515 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -47.52 -70.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 6' ' ' PHE . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 12' ' ' PHE . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.3 pp -64.39 -21.79 66.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -61.59 -35.39 77.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.734 0.302 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.878 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.46 -50.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.222 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.73 74.98 1.41 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.022 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.531 ' CD2' HG23 ' A' ' 5' ' ' THR . 7.2 p90 -99.96 -29.12 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 4' ' ' TYR . 11.3 p -90.08 -38.95 13.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.05 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 -49.69 -59.82 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 6' ' ' PHE . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' ILE . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 15' ' ' LEU . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.2 pp -67.73 -22.98 65.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -43.81 59.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.884 0.373 . . . . 0.0 111.201 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.928 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.842 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 2' ' ' VAL . 23.1 t -112.76 8.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.39 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.3 -35.25 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.293 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.88 -32.44 8.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 111.03 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.6 t80 -56.75 -64.29 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 6' ' ' PHE . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 -45.36 89.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.17 48.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.264 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.017 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.785 0.326 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.32 -25.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -77.11 166.04 23.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.33 153.73 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -52.46 63.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -53.63 -65.54 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.266 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 6' ' ' PHE . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.632 ' N ' HD23 ' A' ' 15' ' ' LEU . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.4 pp -71.86 -25.49 61.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.97 79.73 1.83 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.8 m120 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.52 -41.14 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -179.84 48.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.64 -63.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.41 -33.52 59.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.088 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 4.1 t80 -48.61 -66.21 0.44 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 15' ' ' LEU . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 15' ' ' LEU . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.7 pp -65.52 -20.65 66.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -46.61 -51.79 14.99 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.9 0.381 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.948 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.789 0.328 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.95 -49.13 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.152 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.61 117.96 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -99.28 175.53 5.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.278 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -59.35 -56.34 23.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -47.7 -59.49 3.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 12' ' ' PHE . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.3 pp -62.87 -18.34 62.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -92.17 25.51 2.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.583 0.23 . . . . 0.0 111.553 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.82 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.92 0.39 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 3' ' ' GLU . 7.1 p -58.37 -41.22 80.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.4 tt0 -97.19 118.22 33.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.941 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -70.12 162.32 28.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.0 t -115.44 -50.0 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.1 0.476 . . . . 0.0 111.132 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.803 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 -48.33 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' THR . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' LEU . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp -65.48 -24.9 67.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.52 53.88 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.4 -59.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -147.26 95.54 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -110.61 155.31 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.221 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -69.37 -47.24 64.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -54.4 -68.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 6' ' ' PHE . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.35 -14.42 59.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -70.56 -28.38 64.86 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.77 0.319 . . . . 0.0 111.347 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.986 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.789 0.328 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.11 -45.49 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.59 2.27 17.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.966 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -119.27 167.27 12.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.997 0.427 . . . . 0.0 111.094 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 6' ' ' PHE . 5.9 t -160.68 -47.95 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.334 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.488 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 -48.46 -60.59 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.055 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 11' ' ' THR . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.79 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.06 -22.24 60.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.44 -58.77 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.058 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.84 0.352 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.12 -26.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.31 66.03 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -179.31 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.097 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -65.13 -49.68 68.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.104 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -51.77 -66.75 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 19' ' ' LEU . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 12' ' ' PHE . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 15' ' ' LEU . 2.3 pp -69.99 -11.11 60.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.97 64.09 1.57 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.959 179.941 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -121.09 -51.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.066 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -113.03 145.62 40.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -101.51 159.23 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.175 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 6' ' ' PHE . 4.9 t -53.05 -49.21 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.208 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.7 t80 -46.72 -69.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.462 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 6' ' ' PHE . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' HD13 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 19' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 16' ' ' ILE . 1.3 pp -67.23 -22.59 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.06 74.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.781 0.324 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.814 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.69 -67.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -106.33 35.16 3.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -100.34 97.69 8.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -93.77 -77.78 0.45 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.761 ' HA ' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 -49.89 -69.4 0.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.694 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 6' ' ' PHE . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' PHE . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.22 -11.5 57.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 36.62 1.05 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 111.3 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.066 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 4' ' ' TYR . 19.9 t -77.84 -23.95 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 74.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -144.78 154.48 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.757 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -89.33 -51.46 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -51.37 -69.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.913 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 16' ' ' ILE . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.3 pp -84.03 5.77 24.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.32 35.29 4.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.891 0.377 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 t -115.53 -21.79 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.596 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -146.94 84.11 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -179.39 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.849 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.3 p -81.83 -37.39 27.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.948 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.1 t80 -49.12 -70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.196 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 5' ' ' THR . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.706 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.6 pp -66.5 -21.62 66.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -61.58 -37.4 83.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.742 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.853 0.359 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.75 -67.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -74.91 115.17 14.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -176.14 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -62.54 -39.6 94.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -50.57 -68.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 16' ' ' ILE . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 12' ' ' PHE . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp -66.47 -21.58 66.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.53 -44.96 46.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 111.268 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.932 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 2' ' ' VAL . 39.7 t -92.0 -13.88 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 67.73 119.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.37 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -174.38 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -44.13 86.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 -54.68 -63.55 1.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 18' ' ' ILE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.523 ' HA ' HD21 ' A' ' 19' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 15' ' ' LEU . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.0 pp -72.22 -25.4 61.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -60.28 -54.93 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.753 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 2' ' ' VAL . 24.8 t 51.9 24.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.496 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.09 -28.96 60.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.47 168.3 9.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.4 t -92.59 -49.85 5.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.268 0.556 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.7 t80 -49.27 -64.63 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.48 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.71 -43.31 69.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.87 44.32 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.032 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.931 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 m120 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.812 0.339 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 t -104.17 -40.26 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.159 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -129.8 72.46 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -50.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.65 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 6' ' ' PHE . 6.1 t -51.52 -47.91 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 110.526 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 5' ' ' THR . 0.7 OUTLIER -46.63 -65.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.399 179.802 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.36 10.54 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.1 -59.48 2.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.137 -179.837 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.842 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.26 -41.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -98.62 129.66 45.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -73.94 93.36 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.466 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -56.63 -36.84 69.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.517 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -46.95 -69.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 5' ' ' THR . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 19' ' ' LEU . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' CD2' HD23 ' A' ' 15' ' ' LEU . 1.7 pp -85.11 12.45 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.22 46.32 1.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 111.185 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.991 179.899 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.417 ' C ' HG23 ' A' ' 2' ' ' VAL . 13.2 t-20 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 1' ' ' ASN . 56.1 t -157.61 -44.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.51 111.35 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.49 143.05 50.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 p -73.54 -63.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.436 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.69 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.9 t80 -44.81 -68.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD13 HD21 ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 HD13 ' A' ' 16' ' ' ILE . 1.4 pp -68.69 -13.3 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.02 -24.04 22.58 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.084 -179.766 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 t -72.24 -28.8 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -65.54 81.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.681 ' HB3' HG22 ' A' ' 7' ' ' THR . 20.1 m-85 -79.86 99.48 7.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.911 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -82.47 -43.74 16.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.5 t80 -48.65 -57.32 6.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HB3' ' A' ' 4' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 6' ' ' PHE . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 15' ' ' LEU . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.56 11.95 9.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.07 25.14 9.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 111.084 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.896 -179.952 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.865 0.365 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t -105.22 -49.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.286 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.29 22.02 5.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.283 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.94 -72.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.749 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 6' ' ' PHE . 5.4 t -56.18 -48.38 76.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' N ' HG23 ' A' ' 5' ' ' THR . 1.1 t80 -42.49 -68.44 0.19 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.863 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp -73.88 -11.29 60.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.78 -32.25 5.77 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.739 0.304 . . . . 0.0 111.581 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.983 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.41 -42.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.912 179.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -115.64 102.18 9.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 179.564 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -81.67 -17.6 47.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.887 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -32.75 20.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.082 0.468 . . . . 0.0 110.751 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.2 t80 -51.09 -64.07 0.93 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.696 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 16' ' ' ILE . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 12' ' ' PHE . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.2 mt -71.31 -38.31 71.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.06 79.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.927 -179.955 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.75 0.309 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.82 -41.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.907 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.74 97.78 5.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.61 143.04 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -67.52 -49.28 64.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.9 0.381 . . . . 0.0 111.152 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -47.38 -68.69 0.17 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.541 HD11 ' HE1' ' A' ' 12' ' ' PHE . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.4 pp -83.43 -20.15 34.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -60.71 -22.67 64.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.702 0.287 . . . . 0.0 111.505 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.33 -56.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.92 44.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.593 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.11 159.83 42.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.179 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 t -94.74 -47.17 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.417 0.627 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -45.68 -56.5 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.405 179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 16' ' ' ILE . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.62 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.84 -24.54 65.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.37 -37.66 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.368 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.894 -179.892 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.59 -47.51 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.337 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -135.68 151.89 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -86.82 85.42 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -75.23 -48.32 23.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 -49.07 -69.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' THR . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 6' ' ' PHE . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 12' ' ' PHE . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 15' ' ' LEU . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp -68.21 -18.27 64.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.76 34.26 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.894 0.378 . . . . 0.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.835 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.66 -51.41 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.252 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.71 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 p -79.21 -35.46 41.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.4 t80 -49.29 -60.29 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 6' ' ' PHE . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 12' ' ' PHE . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' CD1' HD12 ' A' ' 15' ' ' LEU . 6.9 mp -56.11 -47.19 78.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.84 53.86 2.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.247 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.154 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.561 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 15' ' ' LEU . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 19' ' ' LEU . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.614 ' HA ' HD21 ' A' ' 19' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' PHE . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 12' ' ' PHE . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.3 t80 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 6' ' ' PHE . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.731 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.9 pp . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.308 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 6' ' ' PHE . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 12' ' ' PHE . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 6' ' ' PHE . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' ILE . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 15' ' ' LEU . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.2 pp . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.6 t80 . . . . . 0 C--O 1.236 0.364 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 6' ' ' PHE . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.359 0.599 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 6' ' ' PHE . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.632 ' N ' HD23 ' A' ' 15' ' ' LEU . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.4 pp . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 4.1 t80 . . . . . 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 15' ' ' LEU . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 15' ' ' LEU . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.7 pp . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 12' ' ' PHE . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.3 pp . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.803 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.17 0.51 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' THR . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' LEU . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 6' ' ' PHE . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 12' ' ' PHE . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.488 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 . . . . . 0 C--O 1.235 0.299 0 CA-C-O 121.27 0.557 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 11' ' ' THR . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.79 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.544 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 19' ' ' LEU . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 12' ' ' PHE . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 15' ' ' LEU . 2.3 pp . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.7 t80 . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.161 0.505 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 6' ' ' PHE . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' HD13 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 19' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 16' ' ' ILE . 1.3 pp . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.761 ' HA ' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.092 0.472 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 6' ' ' PHE . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' PHE . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.161 0.505 . . . . 0.0 110.913 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 16' ' ' ILE . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.3 pp . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.1 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.987 0.422 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 6' ' ' PHE . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.706 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.6 pp . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.175 0.512 . . . . 0.0 110.902 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 16' ' ' ILE . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 12' ' ' PHE . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 18' ' ' ILE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.523 ' HA ' HD21 ' A' ' 19' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 15' ' ' LEU . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.0 pp . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.7 t80 . . . . . 0 C--O 1.237 0.433 0 CA-C-O 121.335 0.588 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.48 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.228 0.537 . . . . 0.0 111.399 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 6' ' ' PHE . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 19' ' ' LEU . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' CD2' HD23 ' A' ' 15' ' ' LEU . 1.7 pp . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.69 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.9 t80 . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD13 HD21 ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 HD13 ' A' ' 16' ' ' ILE . 1.4 pp . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.5 t80 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 10' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 6' ' ' PHE . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 15' ' ' LEU . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 121.39 0.614 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.2 t80 . . . . . 0 C--O 1.237 0.416 0 CA-C-O 121.347 0.594 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 16' ' ' ILE . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 12' ' ' PHE . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.2 mt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.541 HD11 ' HE1' ' A' ' 12' ' ' PHE . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.4 pp . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-O 121.216 0.532 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 16' ' ' ILE . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.62 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.154 0.502 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' THR . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 6' ' ' PHE . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 12' ' ' PHE . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 15' ' ' LEU . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.4 t80 . . . . . 0 C--O 1.235 0.323 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 6' ' ' PHE . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 12' ' ' PHE . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.562 ' CD1' HD12 ' A' ' 15' ' ' LEU . 6.9 mp . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 43.6 t30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.818 0.342 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.436 HG12 ' HG3' ' A' ' 3' ' ' GLU . 53.1 t -100.6 -70.24 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.212 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HG3' HG12 ' A' ' 2' ' ' VAL . 31.4 mt-10 -114.73 -49.79 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.055 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -73.46 98.04 2.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.96 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 p -90.14 -81.91 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 -49.11 -66.95 0.31 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.276 0.56 . . . . 0.0 111.136 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 p -53.97 -37.75 64.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.445 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.58 -39.05 59.68 Favored Glycine 0 C--O 1.226 -0.355 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.281 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.9 mt -64.33 -46.79 92.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.391 0.615 . . . . 0.0 109.772 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 22.0 m-85 -68.38 -42.7 78.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.083 -178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -60.78 -53.45 57.2 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.01 0.91 . . . . 0.0 108.734 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 15' ' ' LEU . 1.4 t80 -62.08 -29.11 70.09 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.99 -1.459 . . . . 0.0 109.639 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' TYR . 0.7 OUTLIER -61.62 -38.13 86.52 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.7 t -65.58 -41.45 92.86 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD23 ' CD2' ' A' ' 19' ' ' LEU . 10.2 tt -55.01 -60.55 3.22 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.326 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.614 ' HA ' HD21 ' A' ' 19' ' ' LEU . 4.3 mm -48.38 -34.56 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.935 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.51 -32.86 74.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.946 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 15' ' ' LEU . 62.8 mt -65.72 -59.03 4.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.449 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 16' ' ' ILE . 0.8 OUTLIER -67.06 -18.31 65.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.477 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.54 70.44 1.38 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.753 0.311 . . . . 0.0 111.212 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.82 -34.77 7.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.18 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -148.6 -52.78 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.745 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.408 ' HB3' ' OG1' ' A' ' 7' ' ' THR . 0.2 OUTLIER -76.55 121.01 22.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.337 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.3 p -82.82 -50.64 8.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.942 0.401 . . . . 0.0 111.788 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -46.38 -67.34 0.29 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.32 0.581 . . . . 0.0 111.894 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 4' ' ' TYR . 10.6 p -50.9 -38.49 50.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.69 -46.67 66.36 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.184 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 6' ' ' PHE . 39.8 mt -53.65 -44.22 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.35 0.595 . . . . 0.0 109.453 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -72.9 -42.44 63.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.468 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.12 -55.51 34.09 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.468 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.2 t80 -55.27 -29.91 59.08 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.507 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -38.57 87.18 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -41.85 97.64 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.797 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.3 tt -55.18 -59.88 4.16 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 12' ' ' PHE . 11.1 mm -45.92 -39.3 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.094 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -57.76 -40.11 78.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.951 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.797 HD12 ' HA ' ' A' ' 15' ' ' LEU . 14.3 mt -61.49 -44.68 98.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.892 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -62.69 -46.42 88.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.848 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.69 70.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.238 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.84 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 t -72.87 -24.35 21.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -108.1 105.85 15.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.816 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -151.34 -59.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.11 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -81.18 -33.64 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.684 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.3 t80 -44.97 -68.65 0.18 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.002 0.429 . . . . 0.0 111.586 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -42.99 69.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.62 -42.56 58.5 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.422 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.684 HD12 ' HA ' ' A' ' 6' ' ' PHE . 24.7 mt -57.3 -43.49 82.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.311 0.576 . . . . 0.0 109.896 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -73.15 -43.05 62.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.806 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.1 -53.89 53.19 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.184 0.993 . . . . 0.0 108.575 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.2 t80 -59.54 -26.01 65.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.782 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -65.35 -39.94 92.97 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' LYS . 0.4 OUTLIER -61.77 -41.06 97.23 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.731 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.3 tt -55.61 -59.49 4.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 15' ' ' LEU . 8.4 mm -49.93 -40.46 16.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.4 mmpt? -57.4 -32.45 66.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.536 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.7 mt -69.04 -58.06 6.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.705 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.9 pp -66.78 -20.08 65.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.532 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.11 60.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.842 0.353 . . . . 0.0 111.449 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.82 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.816 0.341 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.37 -36.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.118 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -80.77 -160.67 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -52.27 128.09 24.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -97.68 -39.55 9.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.515 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.704 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -47.52 -70.31 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.25 0.548 . . . . 0.0 111.645 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.58 -35.72 61.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.76 -45.48 90.98 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 6' ' ' PHE . 16.9 mt -53.33 -42.77 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 109.399 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -73.78 -42.4 61.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.274 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.461 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.03 -56.12 26.32 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.461 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.74 -32.31 69.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 113.653 -1.612 . . . . 0.0 110.011 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -57.7 -43.77 85.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -42.2 98.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.5 tt -55.04 -60.44 3.37 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.32 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 12' ' ' PHE . 9.9 mm -44.99 -39.0 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.398 178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -34.62 76.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 15' ' ' LEU . 27.0 mt -65.96 -54.57 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.3 pp -64.39 -21.79 66.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.27 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -61.59 -35.39 77.7 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.734 0.302 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.878 -179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.77 0.319 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.46 -50.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.222 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.73 74.98 1.41 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.022 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.531 ' CD2' HG23 ' A' ' 5' ' ' THR . 7.2 p90 -99.96 -29.12 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 4' ' ' TYR . 11.3 p -90.08 -38.95 13.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.05 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.3 t80 -49.69 -59.82 3.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -54.78 -40.14 69.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.276 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.75 -44.31 86.75 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.066 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 6' ' ' PHE . 85.0 mt -53.88 -41.66 49.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.294 0.568 . . . . 0.0 109.579 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 28.4 m-85 -75.61 -43.01 50.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.238 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.6 -55.62 32.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.039 0.923 . . . . 0.0 108.71 178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.0 t80 -56.27 -32.62 64.7 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.157 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.95 -43.82 91.34 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.98 -43.59 98.52 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 18' ' ' ILE . 6.1 tt -56.13 -55.26 35.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.258 178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.503 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.3 mm -49.56 -39.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.085 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.92 -33.66 72.16 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.275 179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 15' ' ' LEU . 51.3 mt -68.69 -57.83 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.2 pp -67.73 -22.98 65.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.999 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -43.81 59.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.884 0.373 . . . . 0.0 111.201 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.928 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.842 0.354 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.656 ' O ' HG12 ' A' ' 2' ' ' VAL . 23.1 t -112.76 8.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -56.39 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.903 0.382 . . . . 0.0 110.827 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -121.3 -35.25 3.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.293 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.88 -32.44 8.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 111.03 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.72 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.6 t80 -56.75 -64.29 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.416 0.627 . . . . 0.0 110.253 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.78 -37.71 63.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.352 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.74 -43.22 86.71 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.03 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.72 HD12 ' HA ' ' A' ' 6' ' ' PHE . 13.2 mt -55.89 -44.31 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.409 0.623 . . . . 0.0 109.396 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -74.01 -39.91 63.27 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.733 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.31 -55.34 36.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.455 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.3 OUTLIER -54.39 -33.28 58.93 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 113.511 -1.677 . . . . 0.0 109.748 178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -39.04 78.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -64.96 -41.09 95.78 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.844 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.0 tt -56.39 -58.59 7.37 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 24.6 mm -46.35 -37.14 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.36 0.6 . . . . 0.0 110.677 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -62.51 -40.69 97.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.612 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.844 HD12 ' HA ' ' A' ' 15' ' ' LEU . 13.9 mt -61.69 -44.56 98.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.018 0.437 . . . . 0.0 110.099 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 -45.36 89.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.552 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.05 -54.17 48.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.264 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.017 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.785 0.326 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.32 -25.08 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -77.11 166.04 23.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.954 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -175.33 153.73 1.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.8 -52.46 63.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.101 0.477 . . . . 0.0 110.889 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.6 OUTLIER -53.63 -65.54 0.55 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.266 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 p -50.76 -41.16 56.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.05 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.78 -48.07 51.53 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.393 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 6' ' ' PHE . 5.5 mt -53.88 -41.93 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.7 m-85 -73.49 -40.65 63.93 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.653 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -58.16 -56.19 25.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.3 t80 -56.9 -29.45 63.02 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.872 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 1.9 mt-10 -60.4 -44.85 95.3 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -59.67 -44.3 93.65 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.671 ' HA ' HD12 ' A' ' 18' ' ' ILE . 3.6 tt -56.62 -55.45 33.83 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.214 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.632 ' N ' HD23 ' A' ' 15' ' ' LEU . 3.0 mm -50.74 -28.96 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.493 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.83 -34.04 68.98 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 15' ' ' LEU . 33.6 mt -62.3 -52.4 60.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.264 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.4 pp -71.86 -25.49 61.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.467 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.97 79.73 1.83 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.021 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.8 m120 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.74 0.305 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.0 t -88.52 -41.14 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -179.84 48.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.64 -63.47 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.41 -33.52 59.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.088 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.587 ' HA ' HD12 ' A' ' 9' ' ' ILE . 4.1 t80 -48.61 -66.21 0.44 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.284 0.564 . . . . 0.0 110.744 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.18 -34.72 64.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.054 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 11' ' ' THR . . . -56.27 -39.11 81.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.948 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.0 mt -63.21 -46.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.296 0.57 . . . . 0.0 110.05 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -71.5 -44.81 64.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.016 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -55.15 -53.21 58.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.178 0.989 . . . . 0.0 108.936 178.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.51 ' CE1' HD13 ' A' ' 15' ' ' LEU . 2.9 t80 -57.61 -30.09 65.04 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.216 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -42.7 86.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 t -62.24 -39.08 91.65 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HA ' HD12 ' A' ' 18' ' ' ILE . 10.0 tt -59.04 -61.48 2.61 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.2 mm -47.59 -38.76 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.587 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -35.51 72.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.204 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.574 HD12 ' HA ' ' A' ' 15' ' ' LEU . 57.5 mt -64.99 -58.79 5.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.322 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 19' ' ' LEU . 4.7 pp -65.52 -20.65 66.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.56 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -46.61 -51.79 14.99 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.9 0.381 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.948 179.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 m120 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.789 0.328 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.95 -49.13 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.152 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -93.61 117.96 30.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.639 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -99.28 175.53 5.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.278 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -59.35 -56.34 23.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.518 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -47.7 -59.49 3.25 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.092 0.472 . . . . 0.0 111.345 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.68 -31.14 35.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.216 0.531 . . . . 0.0 109.897 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -62.98 -40.7 99.62 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.1 mt -55.08 -41.05 57.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 35.8 m-85 -76.91 -41.98 41.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.043 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.64 -57.23 13.85 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -54.84 -32.77 60.96 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.67 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -57.69 -39.19 76.57 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -40.43 95.52 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.8 tt -57.46 -61.85 2.2 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.0 178.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HD11 ' CE2' ' A' ' 12' ' ' PHE . 8.0 mm -45.2 -37.21 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.989 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -41.53 85.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.556 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.405 ' N ' ' O ' ' A' ' 15' ' ' LEU . 60.5 mt -59.92 -59.93 3.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.46 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.3 pp -62.87 -18.34 62.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.479 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -92.17 25.51 2.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.583 0.23 . . . . 0.0 111.553 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.82 179.818 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.92 0.39 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 3' ' ' GLU . 7.1 p -58.37 -41.22 80.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.236 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.4 tt0 -97.19 118.22 33.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.941 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -70.12 162.32 28.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.0 t -115.44 -50.0 2.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.1 0.476 . . . . 0.0 111.132 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.803 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 -48.33 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.15 -34.43 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.578 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' HG22 ' A' ' 11' ' ' THR . . . -58.4 -43.32 95.85 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.803 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -56.62 -42.58 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -74.34 -41.82 60.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.795 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.77 -54.6 44.42 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 0.5 OUTLIER -56.24 -29.71 61.4 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.426 178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.77 -46.41 87.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.1 t -58.31 -43.21 88.06 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HA ' HD12 ' A' ' 18' ' ' ILE . 9.4 tt -54.69 -57.8 10.06 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.275 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.472 ' HA ' HD23 ' A' ' 19' ' ' LEU . 16.8 mm -46.44 -41.06 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.776 178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -35.68 71.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.203 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 15' ' ' LEU . 44.7 mt -64.58 -56.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.573 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' A' ' 16' ' ' ILE . 1.1 pp -65.48 -24.9 67.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.945 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.52 53.88 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 p30 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -116.4 -59.34 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -147.26 95.54 2.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -110.61 155.31 22.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.221 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.5 p -69.37 -47.24 64.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -54.4 -68.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.282 0.563 . . . . 0.0 111.008 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -51.23 -42.93 61.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.806 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.73 -47.44 58.45 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.296 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.732 HD12 ' HA ' ' A' ' 6' ' ' PHE . 15.3 mt -52.31 -43.66 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.241 0.543 . . . . 0.0 110.015 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -74.95 -43.13 55.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.475 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.86 -55.95 27.82 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.904 0.859 . . . . 0.0 108.794 178.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -55.42 -31.41 61.85 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.966 -1.47 . . . . 0.0 110.179 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -41.8 96.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.74 -38.27 89.86 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.6 tt -58.84 -61.6 2.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 5.9 mm -44.03 -34.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.295 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -44.73 93.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.619 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -53.96 -54.09 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.626 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.2 pp -77.35 -14.42 59.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.733 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -70.56 -28.38 64.86 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.77 0.319 . . . . 0.0 111.347 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mtt180 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.986 -179.875 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.789 0.328 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.11 -45.49 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.59 2.27 17.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.966 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -119.27 167.27 12.02 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.997 0.427 . . . . 0.0 111.094 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 6' ' ' PHE . 5.9 t -160.68 -47.95 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.334 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.488 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.4 t80 -48.46 -60.59 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.055 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -55.09 -39.32 69.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.298 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 11' ' ' THR . . . -54.11 -43.79 73.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.158 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.6 mt -55.85 -45.05 79.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.16 -39.2 72.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -64.23 -55.72 19.62 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.2 -27.22 32.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.045 -1.434 . . . . 0.0 109.951 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.07 -38.87 72.44 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -37.72 88.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.79 ' HA ' HD12 ' A' ' 18' ' ' ILE . 7.4 tt -54.95 -62.22 1.8 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.837 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 15' ' ' LEU . 4.7 mm -46.29 -33.05 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.932 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -36.42 80.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.79 HD12 ' HA ' ' A' ' 15' ' ' LEU . 25.9 mt -62.86 -52.71 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.06 -22.24 60.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.283 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.44 -58.77 6.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.918 0.389 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtt-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.058 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 p30 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.84 0.352 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 t -70.12 -26.26 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.195 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -99.31 66.03 1.46 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -179.31 -37.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.097 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -65.13 -49.68 68.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.104 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.544 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -51.77 -66.75 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.767 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.9 t -55.68 -43.6 76.53 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.989 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -46.76 -29.22 4.13 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.786 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.2 mt -77.79 -40.37 27.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.4 m-85 -74.22 -43.71 56.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.739 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -59.17 -52.32 66.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.936 0.874 . . . . 0.0 109.569 178.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.482 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.3 t80 -60.91 -28.3 68.81 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.557 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -59.54 -44.1 93.31 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 p -58.75 -41.7 87.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 19' ' ' LEU . 9.2 tt -55.96 -62.42 1.71 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.3 178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 12' ' ' PHE . 6.5 mm -45.74 -38.17 2.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.318 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -38.09 80.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -62.98 -57.84 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.582 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.528 HD23 HD23 ' A' ' 15' ' ' LEU . 2.3 pp -69.99 -11.11 60.63 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.955 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -135.97 64.09 1.57 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.808 0.337 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.959 179.941 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.1 t -121.09 -51.86 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.066 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -113.03 145.62 40.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.759 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -101.51 159.23 15.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.175 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 6' ' ' PHE . 4.9 t -53.05 -49.21 66.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.208 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.563 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.7 t80 -46.72 -69.21 0.14 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.462 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -52.17 -41.5 62.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.604 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.87 -46.47 60.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.282 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.563 HD12 ' HA ' ' A' ' 6' ' ' PHE . 20.2 mt -54.56 -43.67 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.295 0.569 . . . . 0.0 109.893 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -72.84 -43.88 62.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.681 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -62.62 -53.42 54.78 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.911 0.863 . . . . 0.0 109.127 178.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.5 t80 -60.53 -24.61 65.49 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.376 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.6 -39.37 77.3 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -38.88 88.47 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' CD2' HD13 ' A' ' 16' ' ' ILE . 8.9 tt -57.08 -62.49 1.71 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.215 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' HA ' HD21 ' A' ' 19' ' ' LEU . 9.0 mm -45.7 -38.14 2.55 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.348 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -61.08 -37.29 82.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.221 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.513 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.0 mm -64.02 -55.92 19.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.306 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 16' ' ' ILE . 1.3 pp -67.23 -22.59 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.138 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.06 74.3 1.47 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.781 0.324 . . . . 0.0 111.068 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.814 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.69 -67.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -106.33 35.16 3.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.834 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -100.34 97.69 8.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.987 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -93.77 -77.78 0.45 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.761 ' HA ' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 -49.89 -69.4 0.12 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.694 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -54.82 -37.98 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.01 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.34 -46.16 80.86 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.761 HD12 ' HA ' ' A' ' 6' ' ' PHE . 12.3 mt -53.32 -44.1 53.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.189 0.519 . . . . 0.0 109.795 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -73.55 -44.0 58.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.29 -55.22 37.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.462 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.8 t80 -57.74 -25.99 61.19 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.257 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.5 -58.52 7.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.946 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.19 -39.32 69.46 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 15' ' ' LEU . 7.1 tt -55.36 -55.93 25.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 12' ' ' PHE . 1.4 mm -50.86 -43.27 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.984 178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.29 67.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.705 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.5 mm -66.83 -54.92 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.173 0.511 . . . . 0.0 111.131 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.22 -11.5 57.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.896 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 36.62 1.05 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 111.3 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.066 179.935 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.5 m120 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.803 0.335 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 4' ' ' TYR . 19.9 t -77.84 -23.95 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 74.89 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.713 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -144.78 154.48 42.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.757 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 p -89.33 -51.46 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -51.37 -69.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.913 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -35.42 61.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -56.16 -29.52 56.24 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.365 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 10.3 mt -75.58 -46.69 36.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.46 0.648 . . . . 0.0 109.888 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -68.11 -40.18 82.62 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.705 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.469 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.0 OUTLIER -61.22 -51.9 67.02 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.4 t80 -58.62 -26.29 63.55 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.976 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -66.63 -48.7 68.61 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.15 -40.41 93.73 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 16' ' ' ILE . 4.7 tt -54.83 -58.78 6.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.459 178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.473 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.3 mm -47.66 -36.6 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.739 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -36.29 83.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.616 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -65.57 -46.19 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.116 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.3 pp -84.03 5.77 24.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.116 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.32 35.29 4.44 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.891 0.377 . . . . 0.0 111.291 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.825 0.345 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 t -115.53 -21.79 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.596 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -146.94 84.11 1.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -179.39 -42.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.849 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 9' ' ' ILE . 3.3 p -81.83 -37.39 27.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.948 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.1 t80 -49.12 -70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.196 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.75 -33.61 70.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.188 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.19 -43.15 93.58 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.409 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 5' ' ' THR . 4.6 mt -63.45 -42.11 95.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.033 0.444 . . . . 0.0 110.951 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 16.8 m-85 -74.94 -47.99 26.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.654 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.1 t -55.67 -50.97 68.84 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.066 0.936 . . . . 0.0 109.243 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.475 ' N ' ' CG2' ' A' ' 11' ' ' THR . 11.8 t80 -67.05 -23.22 65.86 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.384 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -66.4 -47.45 73.25 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -37.25 83.57 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 16' ' ' ILE . 1.3 tt -58.26 -54.81 42.76 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.706 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.9 mm -52.07 -43.06 36.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.992 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -34.81 63.94 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.504 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.4 mm -67.32 -57.35 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.919 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.6 pp -66.5 -21.62 66.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.148 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -61.58 -37.4 83.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 22.3 mtm-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.742 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 12.7 m120 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.853 0.359 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.75 -67.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -74.91 115.17 14.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.957 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -176.14 -44.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -62.54 -39.6 94.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.8 OUTLIER -50.57 -68.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -44.74 64.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.704 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 11' ' ' THR . . . -51.8 -46.63 54.45 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.507 179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 6' ' ' PHE . 18.1 mt -53.31 -42.79 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.278 0.561 . . . . 0.0 109.828 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -74.55 -41.72 60.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.114 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -54.63 -56.88 14.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.231 1.015 . . . . 0.0 108.465 178.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 16' ' ' ILE . 2.7 t80 -54.55 -34.93 62.67 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.875 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.66 -53.1 33.75 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.034 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -33.12 72.22 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -66.34 -39.61 89.3 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.448 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 ' CE1' ' A' ' 12' ' ' PHE . 38.0 mm -62.45 -34.37 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.214 0.531 . . . . 0.0 109.707 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -37.5 87.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.328 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 15' ' ' LEU . 28.6 mt -64.88 -54.46 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.085 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.566 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp -66.47 -21.58 66.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.212 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.53 -44.96 46.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 111.268 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.932 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.785 0.326 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 2' ' ' VAL . 39.7 t -92.0 -13.88 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 67.73 119.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.878 0.37 . . . . 0.0 111.208 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -174.38 -42.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.882 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.88 -44.13 86.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.626 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.537 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 -54.68 -63.55 1.12 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.694 0.759 . . . . 0.0 110.707 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.2 t -58.15 -42.1 85.19 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.82 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.03 -30.07 7.05 Favored Glycine 0 N--CA 1.461 0.32 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.692 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.0 mt -75.96 -39.06 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 7' ' ' THR . 22.6 m-85 -76.34 -33.8 58.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.611 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -63.16 -57.44 10.52 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.474 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.7 t80 -54.58 -31.78 57.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.659 -1.61 . . . . 0.0 110.246 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.62 -38.89 92.84 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.2 t -63.61 -39.3 94.02 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' HD12 ' A' ' 18' ' ' ILE . 8.5 tt -57.09 -62.54 1.68 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.103 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.523 ' HA ' HD21 ' A' ' 19' ' ' LEU . 5.7 mm -45.97 -31.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.227 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -35.96 81.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.475 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.628 HD12 ' HA ' ' A' ' 15' ' ' LEU . 20.5 mt -66.49 -51.49 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 16' ' ' ILE . 2.0 pp -72.22 -25.4 61.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -60.28 -54.93 39.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.203 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.753 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.666 ' O ' HG12 ' A' ' 2' ' ' VAL . 24.8 t 51.9 24.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.496 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -75.09 -28.96 60.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -101.47 168.3 9.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 6' ' ' PHE . 4.4 t -92.59 -49.85 5.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.268 0.556 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.7 t80 -49.27 -64.63 0.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.911 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.11 -36.48 60.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.614 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 11' ' ' THR . . . -55.66 -44.16 86.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.304 -0.951 . . . . 0.0 111.083 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.56 HD12 ' HA ' ' A' ' 6' ' ' PHE . 7.3 mt -56.45 -44.27 79.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.461 ' OH ' ' CE2' ' A' ' 6' ' ' PHE . 21.9 m-30 -72.51 -41.38 65.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.673 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -61.38 -54.86 38.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.7 t80 -58.87 -23.46 60.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.273 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.99 -41.75 81.83 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -36.69 82.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 12' ' ' PHE . 9.7 tt -57.83 -62.16 2.0 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.6 mm -45.94 -44.03 4.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -42.22 62.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.345 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.48 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.3 mm -62.53 -37.18 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.403 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.71 -43.31 69.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.441 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.87 44.32 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.032 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.931 179.978 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 27.0 m120 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.812 0.339 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 t -104.17 -40.26 6.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.159 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -129.8 72.46 1.48 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.826 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.92 -50.06 0.82 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.65 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.441 HG23 ' N ' ' A' ' 6' ' ' PHE . 6.1 t -51.52 -47.91 63.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.448 0.642 . . . . 0.0 110.526 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 5' ' ' THR . 0.7 OUTLIER -46.63 -65.79 0.5 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.399 179.802 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -52.16 -41.99 63.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.804 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -52.92 -44.52 61.66 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.397 179.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 6' ' ' PHE . 54.0 mt -57.39 -42.46 80.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.092 0.472 . . . . 0.0 110.043 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -73.69 -44.35 56.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.795 -178.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -59.46 -52.55 65.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.325 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.459 ' N ' ' CG2' ' A' ' 11' ' ' THR . 1.9 t80 -60.99 -23.97 65.78 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.681 -1.6 . . . . 0.0 109.908 178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.98 -34.91 77.44 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.36 -43.59 98.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.03 -64.38 0.83 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.608 177.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -44.41 -34.0 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.767 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -38.46 70.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.74 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.1 mm -63.81 -35.38 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.03 0.443 . . . . 0.0 110.949 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.36 10.54 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.141 -179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.1 -59.48 2.75 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.137 -179.837 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.842 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.26 -41.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.17 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -98.62 129.66 45.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.958 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -73.94 93.36 2.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.466 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -56.63 -36.84 69.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.517 -179.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -46.95 -69.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.297 0.57 . . . . 0.0 111.477 -179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 10' ' ' TYR . 6.7 t -56.76 -43.54 80.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.063 0.458 . . . . 0.0 109.972 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -47.34 -28.68 4.74 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.763 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 5' ' ' THR . 4.9 mt -79.66 -37.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 7' ' ' THR . 31.2 m-85 -76.19 -36.83 58.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.545 -178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 1.3 t -65.01 -50.78 64.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.01 0.909 . . . . 0.0 108.559 178.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.5 t80 -64.38 -23.58 67.34 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.782 178.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' OE2' ' NZ ' ' A' ' 17' ' ' LYS . 9.3 tt0 -65.28 -48.34 73.52 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.74 -39.43 73.94 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.452 HD23 ' CD2' ' A' ' 19' ' ' LEU . 8.2 tt -56.17 -62.98 1.34 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.0 mm -43.3 -36.59 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.824 178.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.412 ' NZ ' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -65.53 -38.62 90.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.23 179.352 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . 4.9 mm -58.69 -47.67 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.909 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' CD2' HD23 ' A' ' 15' ' ' LEU . 1.7 pp -85.11 12.45 7.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.921 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -142.22 46.32 1.63 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.813 0.339 . . . . 0.0 111.185 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 mtt-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.991 179.899 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.417 ' C ' HG23 ' A' ' 2' ' ' VAL . 13.2 t-20 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.702 0.287 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 1' ' ' ASN . 56.1 t -157.61 -44.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.36 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -67.51 111.35 4.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.916 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.49 143.05 50.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.2 p -73.54 -63.52 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.436 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.69 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.9 t80 -44.81 -68.74 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.134 0.492 . . . . 0.0 111.669 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.1 p -57.91 -42.83 85.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.432 179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -52.66 -36.81 49.57 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.559 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.7 mt -64.04 -47.12 91.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.239 0.542 . . . . 0.0 110.004 179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -70.08 -44.25 69.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.134 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -56.43 -56.33 22.52 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.029 0.919 . . . . 0.0 108.803 178.521 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.0 t80 -61.36 -32.74 72.64 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -55.74 -43.73 76.88 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -32.47 72.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.07 -34.82 79.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.495 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD13 HD21 ' A' ' 19' ' ' LEU . 19.0 mm -65.78 -37.09 79.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -36.57 75.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.78 179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.3 mt -63.13 -60.47 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.304 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD21 HD13 ' A' ' 16' ' ' ILE . 1.4 pp -68.69 -13.3 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.876 179.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.02 -24.04 22.58 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.6 ptt-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.084 -179.766 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.828 0.347 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.7 t -72.24 -28.8 29.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -65.54 81.69 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.748 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.681 ' HB3' HG22 ' A' ' 7' ' ' THR . 20.1 m-85 -79.86 99.48 7.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.911 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -82.47 -43.74 16.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.177 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.567 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.5 t80 -48.65 -57.32 6.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.302 0.572 . . . . 0.0 110.818 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.681 HG22 ' HB3' ' A' ' 4' ' ' TYR . 4.1 t -62.72 -42.07 99.47 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -48.29 -29.34 6.96 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.547 178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 6' ' ' PHE . 6.0 mt -78.27 -37.79 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.992 -0.604 . . . . 0.0 109.471 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.4 m-85 -77.06 -43.14 35.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.845 -178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -58.98 -53.09 62.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.996 0.903 . . . . 0.0 109.076 178.395 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' N ' ' CG2' ' A' ' 11' ' ' THR . 7.1 t80 -61.01 -30.95 70.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.097 -1.41 . . . . 0.0 109.245 179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 2.6 mt-10 -59.08 -38.4 79.4 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.69 -43.2 97.34 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -56.75 -56.45 21.37 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.169 178.363 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 15' ' ' LEU . 47.7 mm -48.65 -43.59 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.139 0.495 . . . . 0.0 110.553 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -44.35 75.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.9 mm -56.38 -49.79 75.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.948 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -85.56 11.95 9.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.792 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.07 25.14 9.78 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.864 0.364 . . . . 0.0 111.084 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.5 mtt-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.274 -0.869 . . . . 0.0 110.896 -179.952 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.865 0.365 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.0 t -105.22 -49.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.286 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -130.29 22.02 5.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.283 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.94 -72.03 0.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 0.0 110.749 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 6' ' ' PHE . 5.4 t -56.18 -48.38 76.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.895 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' N ' HG23 ' A' ' 5' ' ' THR . 1.1 t80 -42.49 -68.44 0.19 Allowed 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.863 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -51.27 -36.47 42.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.761 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.31 -43.27 64.81 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.361 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.55 -45.85 96.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.391 0.615 . . . . 0.0 109.587 178.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -68.87 -42.73 76.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.247 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -61.19 -54.0 49.83 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.878 0.847 . . . . 0.0 108.952 178.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' N ' ' CG2' ' A' ' 11' ' ' THR . 3.6 t80 -57.39 -24.31 54.64 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.444 179.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -52.03 47.46 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.219 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 p -55.99 -37.99 69.86 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' C ' HD23 ' A' ' 15' ' ' LEU . 8.3 tt -59.2 -58.11 10.08 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -51.64 -38.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.124 178.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -37.17 79.0 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.294 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.498 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.2 mm -62.52 -54.3 35.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.059 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pp -73.88 -11.29 60.32 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.947 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.78 -32.25 5.77 Favored 'General case' 0 N--CA 1.461 0.083 0 CA-C-O 120.739 0.304 . . . . 0.0 111.581 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.983 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.41 -42.09 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.912 179.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -115.64 102.18 9.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 179.564 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -81.67 -17.6 47.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.887 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -32.75 20.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.082 0.468 . . . . 0.0 110.751 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 9' ' ' ILE . 1.2 t80 -51.09 -64.07 0.93 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.696 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.27 -38.23 70.88 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.634 179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 12' ' ' PHE . . . -53.39 -32.37 44.78 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.432 179.395 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 6' ' ' PHE . 8.5 mt -72.63 -47.67 49.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.292 0.568 . . . . 0.0 109.889 179.172 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 13' ' ' GLU . 24.8 m-85 -67.43 -42.23 83.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.677 -179.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.63 -53.16 61.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.066 0.936 . . . . 0.0 109.221 178.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.568 ' CE1' HD11 ' A' ' 16' ' ' ILE . 3.8 t80 -63.72 -31.5 72.7 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.69 179.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -54.99 -52.98 61.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.662 179.39 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 m -58.87 -32.99 69.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.641 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.75 -46.62 78.15 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.441 178.653 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 12' ' ' PHE . 35.4 mm -54.3 -40.52 48.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.096 0.475 . . . . 0.0 110.138 178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -48.02 81.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.463 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.7 mm -52.55 -38.36 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.183 0.516 . . . . 0.0 110.621 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 19' ' ' LEU . 1.2 mt -71.31 -38.31 71.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.437 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.26 -35.06 79.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.192 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.927 -179.955 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.75 0.309 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.82 -41.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 0.0 110.907 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.74 97.78 5.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.854 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.61 143.04 30.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -67.52 -49.28 64.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.9 0.381 . . . . 0.0 111.152 -179.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.582 ' HA ' HD12 ' A' ' 9' ' ' ILE . 0.7 OUTLIER -47.38 -68.69 0.17 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.342 0.591 . . . . 0.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -58.04 -35.73 71.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.555 -179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.23 -36.7 76.79 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.247 179.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 6' ' ' PHE . 11.6 mt -65.52 -45.59 92.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.168 0.508 . . . . 0.0 110.0 179.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -71.53 -44.94 63.69 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.646 -179.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.482 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -54.59 -54.62 39.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.09 0.947 . . . . 0.0 109.289 178.969 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.541 ' HE1' HD11 ' A' ' 16' ' ' ILE . 4.1 t80 -57.09 -31.87 65.7 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.449 179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.41 -51.9 63.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.655 179.073 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.66 -31.72 69.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 177.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.07 -38.59 82.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.415 178.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.541 HD11 ' HE1' ' A' ' 12' ' ' PHE . 47.1 mm -63.65 -33.25 60.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.088 0.47 . . . . 0.0 110.174 177.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -44.49 85.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.434 179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.551 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.5 mm -57.62 -44.61 85.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.029 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.42 ' C ' HD12 ' A' ' 19' ' ' LEU . 2.4 pp -83.43 -20.15 34.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.348 179.715 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 16' ' ' ILE . . . -60.71 -22.67 64.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.702 0.287 . . . . 0.0 111.505 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.834 0.349 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.33 -56.96 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.094 0.473 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.92 44.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.593 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.11 159.83 42.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.179 -179.776 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 t -94.74 -47.17 6.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.417 0.627 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -45.68 -56.5 5.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.405 179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.39 -33.66 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 11' ' ' THR . . . -57.66 -43.21 94.47 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 178.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.7 mt -57.61 -42.02 80.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.374 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.462 ' OH ' ' CE1' ' A' ' 6' ' ' PHE . 24.1 m-85 -74.26 -40.69 62.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.665 -179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -62.24 -53.82 49.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' N ' ' CG2' ' A' ' 11' ' ' THR . 2.6 t80 -59.86 -27.34 66.58 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.76 -1.563 . . . . 0.0 110.315 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -43.67 93.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.849 179.636 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.5 m -62.51 -43.29 99.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 16' ' ' ILE . 3.0 tt -54.36 -56.89 14.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.51 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.62 ' N ' HD23 ' A' ' 15' ' ' LEU . 1.8 mm -49.2 -41.53 14.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.607 179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -56.28 -38.3 71.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.882 179.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 mm -61.1 -58.83 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.909 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.84 -24.54 65.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.115 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.37 -37.66 56.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.368 -179.889 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.894 -179.892 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.896 0.379 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.59 -47.51 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.337 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -135.68 151.89 50.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 179.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -86.82 85.42 7.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.8 p -75.23 -48.32 23.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.1 t80 -49.07 -69.22 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.075 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -52.82 -36.2 58.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.54 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.453 ' O ' HG22 ' A' ' 11' ' ' THR . . . -59.03 -40.02 95.01 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.34 179.195 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 6' ' ' PHE . 37.2 mt -60.07 -41.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.411 0.624 . . . . 0.0 109.589 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' OH ' ' CZ ' ' A' ' 6' ' ' PHE . 17.1 m-30 -75.85 -43.55 45.21 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.298 -179.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.471 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -54.54 -55.14 32.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.127 0.965 . . . . 0.0 108.827 178.479 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 3.3 t80 -57.84 -33.05 68.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 113.569 -1.65 . . . . 0.0 109.135 178.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -52.39 -50.96 61.42 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.959 179.04 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.9 t -62.43 -31.74 72.49 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.44 -39.05 88.65 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.4 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 ' CE1' ' A' ' 12' ' ' PHE . 41.2 mm -64.62 -39.8 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.071 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -34.7 66.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.682 179.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.581 HD12 ' HA ' ' A' ' 15' ' ' LEU . 31.9 mt -70.47 -55.73 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.569 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 19' ' ' LEU . 3.0 pp -68.21 -18.27 64.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.306 179.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.76 34.26 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.894 0.378 . . . . 0.0 111.32 179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.835 179.837 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.4 t -122.66 -51.41 2.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.252 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.71 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.99 99.62 7.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.752 179.826 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 p -79.21 -35.46 41.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.871 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.59 ' HA ' HD12 ' A' ' 9' ' ' ILE . 3.4 t80 -49.29 -60.29 2.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.307 0.575 . . . . 0.0 111.037 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.8 p -57.46 -42.08 81.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.477 179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' THR . . . -53.01 -43.78 61.84 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.322 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 6' ' ' PHE . 35.4 mt -54.72 -46.24 73.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.44 -44.11 71.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.437 -179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.2 -57.15 13.86 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.195 0.998 . . . . 0.0 108.623 178.455 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 15' ' ' LEU . 2.9 t80 -57.52 -34.24 68.9 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.887 179.524 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -53.08 41.67 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.017 179.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -33.73 71.12 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.21 -41.24 90.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.451 178.682 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.522 HD11 ' CE1' ' A' ' 12' ' ' PHE . 49.0 mm -61.62 -41.42 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-O 121.291 0.567 . . . . 0.0 109.773 177.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.17 -44.68 75.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.457 179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD13 ' N ' ' A' ' 18' ' ' ILE . 3.7 mm -55.77 -50.16 69.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-O 121.246 0.546 . . . . 0.0 110.549 179.414 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 ' CD1' HD12 ' A' ' 15' ' ' LEU . 6.9 mp -56.11 -47.19 78.56 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.037 179.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.84 53.86 2.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.247 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.154 -179.961 . . . . . . . . 0 0 . 1 stop_ save_